[12] Patent
[11] Patent No.:GC0007588  
[45] Date of Publishing the Grant of the Patent: 30/Apr /2018                48/2018  
Number of the Decision to Grant the Patent:2018/126039
Date of the Decision to Grant the Patent:15/Apr/2018

[21] Application No.:GC 2014-26500

[22] Filing Date:23/2/2014

[72] Inventors:1- BROWN, Matthew Frank،2- FENWICK, Ashley Edward،3- FLANAGAN, Mark Edward،4- GONZALES, Andrea،5- JOHNSON, Timothy Allan،6- KAILA, Neelu،7- MITTON-FRY, Mark J.،8- STROHBACH, Joseph Walter،9- TENBRINK, Ruth E.،10- TRZUPEK, John David،11- UNWALLA, Rayomand Jal،12- VAZQUEZ, Michael L.،13- Mihir.d.parikh nationality india

[73] Owner: PFIZER INC, 235 East 42nd street, New York 10017, USA

[74] Agent: Altamimi & Company for Advocates & Consultants

  

 

  

[51]IPC:
Int. Cl.: A61K 31/519, 31/5386 (2006.01)

[56] Cited Documents:

-WO 2011045702A1 (PFIZER [US]; ACKER BRADALAN [US]; HARTMANN SUSAN J [US]HUANGHORNG-) 21 ApriI 2011
-WO 2011075334 A1(PFIZER [US]; XIE JIN[US]; PROMO MICHELE ANN [US]JACOBSENERIC JON [) 23 June 2011
-WO 2010020905 A1 (PFIZER [US]; BERLINSKIPAMELA JO [US]BIRCHMEIER MATTHEW JOSEPH[US];) 25 February 2010
 
Examiner: PH. Mohammad S. AlMousa

[54] PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES
[57] Abstract: Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.
No. of claims: 10


 

Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.